Champions Oncology (CSBR) Operating Leases (2019 - 2026)

Champions Oncology (CSBR) has 8 years of Operating Leases data on file, last reported at $10.3 million in Q3 2026.

• On a quarterly basis, Operating Leases rose 78.28% year-over-year to $10.3 million in Q3 2026; TTM through Jul 2026 was $10.3 million, a 78.28% increase from a year earlier, with the FY2026 full-year figure at $3.0 million, down 35.43% from the prior year.
• Operating Leases for Q3 2026 stood at $10.3 million, up from $3.0 million in the prior quarter.
• Across five years, Operating Leases topped out at $10.3 million in Q3 2026 and bottomed at $3.0 million in Q2 2026.
• Historically, Operating Leases has averaged $7.1 million across 5 years, with a median of $7.4 million in 2023.
• The largest YoY upside for Operating Leases was 78.28% in 2026 against a maximum downside of 35.43% in 2026.
• Year by year, Operating Leases stood at $9.0 million in 2022, then retreated by 10.21% to $8.0 million in 2023, then retreated by 15.84% to $6.8 million in 2024, then declined by 22.23% to $5.3 million in 2025, then soared by 94.55% to $10.3 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $10.3 million in Q3 2026, $3.0 million in Q2 2026, and $4.9 million in Q1 2026.